Crohn's-like enterocolitis associated with mycophenolic acid treatment

Gut

Volumn 57, Issue 9, 2008, Pages 1330-

  Dost, D ^a   Van Leerdam, M E ^a   Van Dokken, H ^a   Weimar, W ^a   Kuipers, E J ^a   Bijl, A H ^b   Van Gelder, T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Pharmacovigilance Centre Lareb   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FINGOLIMOD; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ABDOMINAL PAIN; COLON MUCOSA; CROHN DISEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOLITIS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; KIDNEY GRAFT; LETTER; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGMOIDOSCOPY;

CROHN DISEASE; ENTEROCOLITIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 50249131542     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.139972     Document Type: Letter

References (9)

1. Hood KA, Zarembski DG. Mycophenolate mofetil; A unique immunosuppressive agent. Am J Health-Syst Pharm 1997;54:285-94.
2. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopnarmacology 2000;47:85-118.
3. Allison AC, Eugui EM. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 2005;80(2S):S181-90.
4. Maes BD, Dalle I, Geboes K. et al. Erosive enterocolitis in mycophenolate mofetil-treated renat-transplant recipients with persistent afebrile diarrhea. Transplantation 2003;75:665-72.
5. Dalle IJ, Maes BD, Geboes KP, et al. Crohn's-like changes in the colon due to mycophenolate? Colorectal Dis 2005;7:27-34.
6. Wieland E, Shipkova M, Schellhaas U. et al. Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem 2000;33:107-13.
7. Shipkova M, Armstrong VW, Oellerich M, et al. Acyl glucuronide drug metabolites: toxological and analytical implications. Ther Drug Monit 2003;25:1-16.
8. Reincker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
9. Stevens C, Walz G, Singaram C, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.